Vimarsana
Biggest News Aggregation in the World

Page 7 - David Werring News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from David Werring. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In David Werring Today - Breaking & Trending Today

Should I be worried about the Oxford/AstraZenica Covid vaccine? Your questions answered - Vimarsana News

Should I be worried about the Oxford/AstraZenica Covid vaccine? Your questions answered

THE benefits of the Oxford/AstraZeneca vaccine continue to outweigh any risks, according to the UK medicines regulator, though under-30s will be offered an alternative jab. That vote of confidence has been backed up by the European medicines watchdog which ruled that unusual blood clots were “very rare side effects” of the jab. Some other European countries have restricted the vaccine’s use in younger people following reports of cerebral venous sinus thrombosis, a specific type of clot that prevents blood from draining from the brain, as well as low platelet counts – cells that ...

What are the symptoms of blood clots? Full list amid AstraZeneca vaccine fears - Vimarsana News

What are the symptoms of blood clots? Full list amid AstraZeneca vaccine fears

What are the symptoms of blood clots? Full list amid AstraZeneca vaccine fears Updated: 8 Apr 2021, 12:26 Invalid Date, PEOPLE who have recently had the AstraZeneca coronavirus jab should seek medical attention if they have "rare side effects" for more than four days after innoculation, experts have urged. Regulators in the UK have now revealed that people under the age of 30 will be offered an alternative to the AstraZeneca coronavirus amid blood clots fears. * Read our coronavirus live blog for the latest news & updates... 3 Regulators have said that people under the age of 30 should be ...

Astrazeneca Covid vaccine Q&A: What we know about blood clots, side effects and risks for under-30s - Vimarsana News

Astrazeneca Covid vaccine Q&A: What we know about blood clots, side effects and risks for under-30s

The UK medicines regulator says the benefits of the AstraZeneca vaccine continue to outweigh any risks 9 April 2021 • 4:19pm The UK medicines regulator has said the benefits of the Oxford/AstraZeneca vaccine continue to outweigh any risks, but under-30s will be offered an alternative jab. Meanwhile, in a separate update on its investigations on Wednesday, the European medicines watchdog has ruled that unusual blood clots were "very rare side effects" of the jab. Scientists have also insisted that further research is needed to understand more about the risk of these rare blood clots. On Ap...

Anticoagulation should not be regarded as primary cause of intracerebral haemorrhages, finds study - Vimarsana News

Anticoagulation should not be regarded as primary cause of intracerebral haemorrhages, finds study

Anticoagulation should not be regarded as primary cause of intracerebral haemorrhages, finds study Cardiovascular diseases are usually complex and affect multiple organs simultaneously. Treatments for vascular diseases in the brain may therefore have implications for the treatment of cardiac diseases. It is therefore important to understand the respective causes and effects. This study explores the causes of intracerebral haemorrhages and links them to the risk of stroke associated with atrial fibrillation. It suggests a fundamental new assessment of the effects of blood thinning on intracer...

Astrazeneca Covid vaccine Q&A: What we know about blood clots, side effects and risks for under-30s - Vimarsana News

Astrazeneca Covid vaccine Q&A: What we know about blood clots, side effects and risks for under-30s

The UK medicines regulator has said the benefits of the Oxford/AstraZeneca vaccine continue to outweigh any risks, but under-30s will be offered an alternative jab. Meanwhile, in a separate update on its investigations on Wednesday, the European medicines watchdog has ruled that unusual blood clots were "very rare side effects" of the jab. Some European countries have restricted the vaccine for younger people following reports of cerebral venous sinus thrombosis (CVST), a specific type of clot that prevents blood from draining from the brain, as well as low platelet counts - cells that help ...